Moberg Pharma AB (publ) Stock: price and insider trades · Sweden

Moberg Pharma AB (publ), classified in the Health Care sector, is a listed company based in Bromma city district, Sweden, founded in 2006. Its insiders report their share dealings to Finansinspektionen. Over the twelve months to 18 October 2026, 14 filings were filed, from 6 insiders.

Both sides are active: 5 purchases worth €14k and 6 sales worth €1.0M, from 2 insiders and 2 insiders respectively. Netting one side against the other leaves €992k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a sale of €465k from Richard Ding, disclosed on 17 August 2026, or 0.99% of market capitalisation. Among those who bought: 2 board members.

Across the 885 companies tracked on its exchange, the median is 7 filings; at 14 filings, this issuer sits above that mark. Our records for Moberg Pharma AB (publ) go back to 2021, with 7 purchases and 6 sales on the open market in total.

The most recent open-market purchase was published on 21 August 2026, 57 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.